Tachycardiomyopathy caused by atrial fibrillation of the tachysystolic form
- 作者: Steklov V.I.1, Demyanenko A.V.1, Morozov D.A.1, Lipskaya M.V.1, Lependin S.O.1, Dzhanelidze T.D.1
-
隶属关系:
- The P.V.Mandryka Central Military Clinical Hospital of the Ministry of Defense of the Russian Federation
- 期: 卷 343, 编号 5 (2022)
- 页面: 57-60
- 栏目: Brief articles
- URL: https://journals.eco-vector.com/0026-9050/article/view/629654
- DOI: https://doi.org/10.52424/00269050_2022_343_5_57
- ID: 629654
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
订阅存取
详细
A clinical case of tachycardiomyopathy induced by atrial fibrillation of the tachysystolic form is presented. The disease was accompanied by a rapid decrease in the left ventricular ejection fraction within 1 year, documented in various medical institutions. The restoration of sinus rhythm and the appointment of optimal drug therapy, combined with a high patient adherence to treatment, led to the restoration of the contractile function of the left ventricle within three calendar months.
作者简介
V. Steklov
The P.V.Mandryka Central Military Clinical Hospital of the Ministry of Defense of the Russian Federation
编辑信件的主要联系方式.
Email: vsteklov@yandex.ru
俄罗斯联邦, Moscow
A. Demyanenko
The P.V.Mandryka Central Military Clinical Hospital of the Ministry of Defense of the Russian Federation
Email: vsteklov@yandex.ru
俄罗斯联邦, Moscow
D. Morozov
The P.V.Mandryka Central Military Clinical Hospital of the Ministry of Defense of the Russian Federation
Email: vsteklov@yandex.ru
俄罗斯联邦, Moscow
M. Lipskaya
The P.V.Mandryka Central Military Clinical Hospital of the Ministry of Defense of the Russian Federation
Email: vsteklov@yandex.ru
俄罗斯联邦, Moscow
S. Lependin
The P.V.Mandryka Central Military Clinical Hospital of the Ministry of Defense of the Russian Federation
Email: vsteklov@yandex.ru
俄罗斯联邦, Moscow
T. Dzhanelidze
The P.V.Mandryka Central Military Clinical Hospital of the Ministry of Defense of the Russian Federation
Email: vsteklov@yandex.ru
俄罗斯联邦, Moscow
参考
- Бокерия Л.А., Шенгелия Л.Д. Изме¬нения в сердце при фибрилляции предсердий. Часть I. Кардиопатия фибрилляции пред¬сердий: новые дилеммы и старые проблемы //Анналы аритмологии. — 2016. — Т. 13, № 3. - С. 138-147.
- Стеклов В.И., Ким Е.А., Крайнюков П.Е. и др. Методы оценки качества жизни боль¬ных с нарушениями ритма сердца // Вестн. аритмологии. — 2021. — № 1. — С. 55—63.
- Стеклов В.И, Морозов ДА., Лепендин С.О. и др. Впервые выявленная фибрилляция пред¬сердий: выбор тактики // IX Всероссийский съезд аритмологов, 20—22 мая 2021 г.; Сб. тез,— СПб, 2021. - С. 119-120.
- Сох J.L. Cardiac surgery for arrhythmias // PACE. - 2004. - Vol. 27. - P. 266-282.
- Deedwania P.C., Singh B.N., Ellenbogen K. et al. Spontaneous conversion and maintenance
- of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the Veterans Affairs Con¬gestive Heart Failure Survival Trial of Anti- arrhythmic Therapy (CHF-STAT). The Depart¬ment of Veterans Affairs CHF-STAT Investi¬gators // Circulation. — 1998. — Vol. 98, Iss. 23. - P. 2574-2579.
- Gopinathannair R., Sullivan R.M., Olshan¬sky B. Tachycardia-Mediated Cardiomyopathy: Recognition and Management // Curr. Heart Fail. Rep. - 2009. - N 6. - P. 257-264.
- Huizar Jose F., Ellenbogen Kenneth A.. Tan Alex Y. et al. Arrhythmia-Induced Cardiomyopathy //J. Am. Coll, cardiol. - 2019. — Vol. 73, N 18. - P. 2328-2344.
- Watanabe H., Okamura K, Chinushi M. et al. Clinical characteristics, treatment, and outcome of tachycardia induced cardiomyo¬pathy // Int. Heart J. - 2008. - Vol. 49, N 1. - P. 39-47.
补充文件
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).